Synta Pharmaceuticals Corp. Earnings Conference Call (Q2 2012) Today's Calls 
Visit the TF Network Sites
Visit the TF Network Sites
· Corporate IR Center
· Institutional Investor Center
· Individual Investor Center
Download Plug-In
Real Player 8 Basic
Windows Media Player
Other Conference Calls
Other Aug 2 Calls
Today's Calls
Call Details
Synta Pharmaceuticals Corp. Earnings Conference Call (Q2 2012)
Scheduled to start Thu, Aug 2, 2012, 10:00 am Eastern

-- this event is ongoing now--
Listen to the ongoing live event audio stream

About Synta Pharmaceuticals Corp (NasdaqGM:SNTA)Other Calls 
Synta Pharmaceuticals Corp., a biopharmaceutical company, focuses on discovering, developing, and commercializing small molecule drugs to extend and enhance the lives of patients with severe medical conditions, including cancer and chronic inflammatory diseases. Its research and development programs include STA-9090, an Hsp90 inhibitor that is in Phase II stage for non-small cell lung cancer and gastrointestinal stromal tumors, as well as in Phase I for hematologic cancers and solid tumors; Elesclomol, an oxidative stress inducer that is in Phase I/II stage for solid and hematologic cancers; and STA-9584, a vascular disrupting agent, which is in preclinical development for cancer. The company’s programs also include Apilimod (STA-5326), an oral IL-12/23 inhibitor, which is in Phase IIa stage for rheumatoid arthritis; and Oral CRACMchannelinhibitor that is in preclinical development for autoimmune diseases and respiratory conditions. It has a partnership with Hoffmann-La Roche for the development of CRACM inhibitors. The company was incorporated in 2000 and is based in Lexington, Massachusetts.

More Info: Quote | Profile | Reports | Research | Insider | Financials | Analyst Ratings

Copyright © 2012 Yahoo! Inc. All Rights Reserved. Privacy Policy - Terms of Service
Copyright © 2012 FirstCall Events. Historical chart data provided by Commodity Systems, Inc. (CSI). Company profile information presented on this page is Copyright Capital IQ. Data and information is provided for informational purposes only, and is not intended for trading purposes. Neither Yahoo nor any of its data or content providers (such as Capital IQ, CSI, etc.) shall be liable for any errors or delays in the content, or for any actions taken in reliance thereon.